NSE List Price : ₹120.00

subscription

Category	Times
QIBs	3.66x
HNIs	5.31x
Retail	3.49x
Total : 3.96x

IPO Market Lot(s) Distribution

Application	Lot Size	Shares	Amount
Retail Minimum	2	2,400	₹283,200
Retail Maximum	2	2,400	₹283,200
S-HNI Minimum	3	3,600	₹424,800
S-HNI Maximum	7	8,400	₹991,200
B-HNI Minimum	8	9,600	₹1,132,800

About the Company

Pramodini Medicare Limited, established in 2000, is among India's prominent diagnostic service providers, offering comprehensive solutions across radiology, clinical laboratory, and nuclear medicine. Its radiology portfolio includes MRI, CT scans, X-rays, ultrasound with colour Doppler, mammography, DEXA scans, and interventional radiology. The company also provides clinical laboratory services covering haematology, microbiology, immunology, pathology, and biochemistry, along with nuclear medicine services such as PET-CT, SPECT, and nuclear therapy.

The company operates its diagnostic centres through multiple business models, including Public-Private Partnerships (PPP), Private-Private Partnerships (Pvt-Pvt), strategic collaborations with Public Sector Undertakings (PSUs), standalone diagnostic centres, and location-specific agreements. Pramodini Medicare has established a presence across several cities, including Vijayawada, Hyderabad, Kurnool, Kadapa, Tirupati, Varanasi, Prayagraj, and other locations across India.

Company Financial Report

_{Amount ₹ in Crores}

Period Ended	Revenue	Expense	PAT	Assets
2024	₹35.79	₹25.72	₹7.14	₹48.78
2025	₹38.55	₹22.80	₹11.14	₹56.45
2026	₹63.38	₹40.08	₹17.38	₹93.62

Company Promoter

Dr. Chalasani Kuldeep Kumar

Dr. Chalasani Kavitha

Ms. Chalasani Durga Aashritha

M/s. Sri Ram Medicare Private Limited

Know before investing

• • Strengths

  Wide geographic presence across India: The company has developed an extensive network of diagnostic centres spanning multiple states. Its growing regional footprint allows it to cater to a diverse patient base through both government and private healthcare institutions.

  Robust technology and IT-driven operations: The company is supported by a strong IT infrastructure that enables radiology, laboratory, nuclear medicine, and round-the-clock teleradiology services. Its technology-driven systems enhance operational efficiency while ensuring effective and reliable service delivery.

• • Risks

  Dependence on government partnership projects: The company generates a significant share of its revenue from Public-Private Partnership (PPP) arrangements with government authorities. Any failure to renew these agreements, changes in contractual terms, or delays in payment receipts may negatively impact its operations, financial condition, and overall business performance.

  Significant reliance on radiology segment: A major portion of the company's revenue is contributed by its radiology services. Any slowdown, disruption, or adverse changes affecting this business segment could have a material impact on the company's revenue, profitability, and long-term growth.

Objects of the Issue & Utilisation of proceeds

Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres.

General corporate purposes and unidentified inorganic acquisition.

Company  Address

Pramodini Medicare Ltd.
D. No: – 29-4-54K, CSI Complex,
Prakasam Road,
Suryaraopet
Vijayawada, Andhra Pradesh, 520002
Phone: +91 9985782727
Email: investors@pramodinidiagnostics.com
Website: https://www.pramodinidiagnostics.com/

IPO Registrar

Purva Sharegistry (India) Pvt. Ltd.
Phone: +91-022-23018261/ 23016761
Email: newissue@purvashare.com
Website: https://www.purvashare.com/investor-service/ipo-query